365 related articles for article (PubMed ID: 15203925)
1. Liposome-mediated DNA immunisation via the subcutaneous route.
Perrie Y; McNeil S; Vangala A
J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
[TBL] [Abstract][Full Text] [Related]
2. Liposome-mediated DNA vaccination: the effect of vesicle composition.
Perrie Y; Frederik PM; Gregoriadis G
Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
[TBL] [Abstract][Full Text] [Related]
3. Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route.
Perrie Y; Barralet JE; McNeil S; Vangala A
Int J Pharm; 2004 Oct; 284(1-2):31-41. PubMed ID: 15454294
[TBL] [Abstract][Full Text] [Related]
4. Liposome-entrapped plasmid DNA: characterisation studies.
Perrie Y; Gregoriadis G
Biochim Biophys Acta; 2000 Jul; 1475(2):125-32. PubMed ID: 10832026
[TBL] [Abstract][Full Text] [Related]
5. Liposome (Lipodine)-mediated DNA vaccination by the oral route.
Perrie Y; Obrenovic M; McCarthy D; Gregoriadis G
J Liposome Res; 2002; 12(1-2):185-97. PubMed ID: 12604053
[TBL] [Abstract][Full Text] [Related]
6. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
7. The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes.
de la Torre LG; Rosada RS; Trombone AP; Frantz FG; Coelho-Castelo AA; Silva CL; Santana MH
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):175-84. PubMed ID: 19540734
[TBL] [Abstract][Full Text] [Related]
8. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
9. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
10. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.
Henriksen-Lacey M; Christensen D; Bramwell VW; Lindenstrøm T; Agger EM; Andersen P; Perrie Y
Mol Pharm; 2011 Feb; 8(1):153-61. PubMed ID: 21117621
[TBL] [Abstract][Full Text] [Related]
12. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids.
Even-Chen S; Barenholz Y
Biochim Biophys Acta; 2000 Dec; 1509(1-2):176-88. PubMed ID: 11118529
[TBL] [Abstract][Full Text] [Related]
13. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
[TBL] [Abstract][Full Text] [Related]
14. Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes.
Birchall JC; Kellaway IW; Mills SN
Int J Pharm; 1999 Jun; 183(2):195-207. PubMed ID: 10361170
[TBL] [Abstract][Full Text] [Related]
15. Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids.
Zhao DD; Watarai S; Lee JT; Kouchi S; Ohmori H; Yasuda T
Acta Med Okayama; 1997 Jun; 51(3):149-54. PubMed ID: 9227794
[TBL] [Abstract][Full Text] [Related]
16. Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies.
McNeil SE; Vangala A; Bramwell VW; Hanson PJ; Perrie Y
Curr Drug Deliv; 2010 Apr; 7(2):175-87. PubMed ID: 20158478
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization.
Chang SF; Yeh CC; Chen PJ; Chang HI
Molecules; 2018 Jan; 23(1):. PubMed ID: 29301300
[TBL] [Abstract][Full Text] [Related]
18. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization.
Jiao X; Wang RY; Feng Z; Alter HJ; Shih JW
Hepatology; 2003 Feb; 37(2):452-60. PubMed ID: 12540796
[TBL] [Abstract][Full Text] [Related]
20. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.
Qu W; Li N; Yu R; Zuo W; Fu T; Fei W; Hou Y; Liu Y; Yang J
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):852-860. PubMed ID: 29447484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
